Validation of radiation volume by analysis of recurrence pattern in breast-conserving treatment for early breast cancer

Journal of Breast Cancer

Volumn 12, Issue 4, 2009, Pages 257-264

  Shim, Su Jung ^a,b   Kim, Yong Bae ^a   Keum, Ki Chang ^a   Lee, Ik Jae ^a   Lee, Hy De ^a   Suh, Chang Ok ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Eulji General Hospital   (South Korea)

Author keywords

Breast conserving surgery; Radiotherapy; Recurrence

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE INTERVAL; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; PARTIAL MASTECTOMY; RADIATION DOSE; SEGMENTAL MASTECTOMY; SURVIVAL RATE; VALIDATION STUDY;

EID: 74849088245     PISSN: 17386756     EISSN: None     Source Type: Journal    
DOI: 10.4048/jbc.2009.12.4.257     Document Type: Article

References (30)

1. Suh CO, Chung EJ, Lee HD, Lee KS, Oh KK, Kim GE. Risk factors for recurrence after conservative treatment in early breast cancer: preliminary report. J Korean Soc Ther Radiol 1997;5:331-7.
2. Suh CO, Lee HD, Lee KS, Jung WH, Oh KK, Kim GE. Conservative surgery and primary radiotherapy for early breast cancer: Yonsei Cancer Center experience. J Korean Soc Ther Radiol 1994;12:337-48.
3. Dombernowsky P, Andersen JA, Andersen KW, Axelsson CK, Blichert-Toft M, Hansen M, et al. Adjuvant chemotherapy in premenopausal and menopausal high-risk patients with breast cancer. 4. Results of the DBCG (Danish Breast Cancer Cooperative Group) 77B study. Ugeskr Laeger 1991;153:2280-3.
4. Recht A, Silver B, Schnitt S, Connolly J, Hellman S, Harris JR. Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency and salvage. Int J Radiat Oncol Biol Phys 1985;11:1271-6.
5. Veronesi U, Banfi A, Salvadori B, Luini A, Saccozzi R, Zucali R, et al. Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial. Eur J Cancer 1990;26:668-70.
6. Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995;333:1456-61.
7. Santiago RJ, Wu L, Harris E, Fox K, Schultz D, Glick J, et al. Fifteen-year results of breast-conserving surgery and definitive irradiation for Stage I and II breast carcinoma: the University of Pennsylvania experience. Int J Radiat Oncol Biol Phys 2004;58:233-40.
8. Halverson KJ, Taylor ME, Perez CA, Garcia DM, Myerson R, Philpott G, et al. Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer. Int J Radiat Oncol Biol Phys 1993;26:593-9.
9. Fisher B, Redmond C, Poisson R, Margolese R, Wolmark N, Wickerham L, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1989;320:822-8.
10. Veronesi U, Zucali R, Del Vecchio M. Conservative treatment of breast cancer with QU.A.R.T. Technique. World J Surg 1985;9:676-81.
11. Recht A, Pierce SM, Abner A, Vicini F, Osteen RT, Love SM, et al. Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 1991;9:988-96.
12. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-41.
13. Louis-Sylvestre C, Clough K, Asselain B, Vilcoq JR, Salmon RJ, Campana F, et al. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. J Clin Oncol 2004;22:97-101.
14. Rutgers EJ, Meijnen P, Bonnefoi H. Clinical trials update of the European Organization for Research and Treatment of Cancer Breast Cancer Group. Breast Cancer Res 2004;6:165-9.
15. Grills IS, Kestin LL, Goldstein N, Mitchell C, Martinez A, Ingold J, et al. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes. Int J Radiat Oncol Biol Phys 2003;56:658-70.
16. Arthur DW, Vicini FA. Accelerated partial breast irradiation as a part of breast conservation therapy. J Clin Oncol 2005;23:1726-35.
17. Kim KJ, Suh CO. Partial Breast Irradiation (PBI). J Korean Breast Cancer Soc 2004;7:65-71.
18. Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997;337:956-62.
19. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997;337:949-55.
20. Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999; 353:1641-8.
21. Handley RS. Carcinoma of the breast. Ann R Coll Surg Engl 1975; 57:59-66.
22. Galper S, Recht A, Silver B, Manola J, Gelman R, Schnitt SJ, et al. Factors associated with regional nodal failure in patients with early stage breast cancer with 0-3 positive axillary nodes following tangential irradiation alone. Int J Radiat Oncol Biol Phys 1999;45:1157-66.
23. Buchholz TA. Internal mammary lymph nodes: to treat or not to treat. Int J Radiat Oncol Biol Phys 2000;46:801-3.
24. Harris EE, Hwang WT, Seyednejad F, Solin LJ. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy. Cancer 2003;98:2144-51.
25. Poortmans PM, Venselaar JL, Struikmans H, Hurkmans CW, Davis JB, Huyskens D, et al. The potential impact of treatment variations on the results of radiotherapy of the internal mammary lymph node chain: a quality-assurance report on the dummy run of EORTC Phase III randomized trial 22922/10925 in Stage I-III breast cancer (1). Int J Radiat Oncol Biol Phys 2001;49:1399-408.
26. Olivotto IA, Chua B, Elliott EA, Parda DS, Pierce LJ, Shepherd L, et al. A clinical trial of breast radiation therapy versus breast plus regional radiation therapy in early-stage breast cancer: the MA20 trial. Clin Breast Cancer 2003;4:361-3.
27. Stemmer SM, Rizel S, Hardan I, Adamo A, Neumann A, Goffman J, et al. The role of irradiation of the internal mammary lymph nodes in high-risk stage II to IIIA breast cancer patients after high-dose chemotherapy: a prospective sequential nonrandomized study. J Clin Oncol 2003;21:2713-8.
28. Andry G, Suciu S, Vico P, Faverly D, Andry-t'Hooft M, Verhest A, et al. Locoregional recurrences after 649 modified radical mastectomies: incidence and significance. Eur J Surg Oncol 1989;15:476-85.
29. Aberizk WJ, Silver B, Henderson IC, Cady B, Harris JR. The use of radiotherapy for treatment of isolated locoregional recurrence of breast carcinoma after mastectomy. Cancer 1986;58:1214-8.
30. Aristei C, Marsella AR, Chionne F, Panizza BM, Marafioti L, Mosconi AM, et al. Regional node failure in patients with four or more positive lymph nodes submitted to conservative surgery followed by radiotherapy to the breast. Am J Clin Oncol 2000;23:217-21.